LATEST
Silgan / Trivium: minority stakenewBF International Best Fields Best Food / DiagramnewEQT agreed to acquire CleanawayNavigator Gas / Navigator HoldingsAlcoa / AliGroupInternational Seaways agreed to acquire BrutonBoston Crest PVT / LQR HouseBrady acquired Productivity Solutions and Services businessJMSB / EFSIVista Equity Partners / PKI Business UnitBluegem Capital Partners / Rispo GroupApax Partners agreed to acquire Odido
Open App
ClosedPublished 20 Nov 2024

Recursion /
Exscientia

Recursion completes combination with Exscientia

Buy side: Recursion
Buy sideRecursion
Target: Exscientia
TargetExscientia
Source · 20 Nov 2024Source-verified
See the source
Buy side: Recursion
Buy sideRecursion
Target: Exscientia
TargetExscientia
01 / BuyerRecursion
02 / TargetExscientia
Source-verified
01

What happened

Recursion has completed its combination with Exscientia, which is now a wholly owned subsidiary. The companies are AI-powered drug discovery and development companies.

Exscientia ADSs ceased trading on Nasdaq and will be delisted.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Recursion completes combination with Exscientia

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.